Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The goal is to increase your activity level
Strength depends on dose, not source
:format(webp))
Targeting one carbon metabolism with an antimetabolite disrupts pyrimidine homeostasis and induces nucleotide overflow
Frequently Asked Questions About BPC-157 in Canada What Should a Certificate of Analysis Include for BPC-157
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
US$ 22.48
US$ 23.55
US$ 22.34
US$ 29.68
US$ 27.68
